| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Finance CFO | SVP Finance &CFO | SVP Controller +1 more
1 company
Fenimore Christopher R. is an EVP Finance CFO at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 58 sells.
Estimated insider holdings value: $11.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sell | 5,680 | $1,205.33 | $6,846,262.22 | -61.9% | -37.2% | -51.7% | |
| Feb 9, 2024 | REGN Regeneron Pharmaceuticals, Inc. | SVP Finance &CFO | Sell | 4,919 | $953.31 | $4,689,319.75 | -4.7% | +1.5% | -25.5% | |
| Dec 27, 2023 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sell | 2,448 | $856.71 | $2,097,226.08 | -14.6% | +10.2% | -18.0% | |
| Dec 22, 2023 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sell | 1,930 | $844.30 | $1,629,501.90 | -3.6% | +14.3% | -17.1% | |
| Mar 23, 2023 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sell | 2,192 | $806.47 | $1,767,782.24 | -10.6% | -2.9% | +20.6% | |
| Oct 5, 2022 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sell | 1,844 | $749.00 | $1,381,156.00 | -10.1% | -3.4% | +11.5% | |
| Oct 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sell | 3,346 | $724.00 | $2,422,504.00 | -15.5% | -2.0% | +10.0% | |
| Aug 23, 2021 | REGN Regeneron Pharmaceuticals, Inc. | SVP Controller | Sale+OE | 4,781 | $655.31 | $3,133,037.10 | -2.4% | -3.5% | -9.7% | |
| Jul 21, 2020 | REGN Regeneron Pharmaceuticals, Inc. | VP Controller | Sale+OE | 3,709 | $642.04 | $2,381,316.95 | -1.5% | - | - | |
| Jun 16, 2020 | REGN Regeneron Pharmaceuticals, Inc. | VP Controller | Sale+OE | 3,556 | $590.89 | $2,101,214.90 | -1.3% | - | - |